Furthermore, heterogeneous methylation of CASK occurred more frequently in CRC patients with lower levels of tumor invasion (T1-T3, P = 0.002) and male patients (P < 0.001) (Supplementary Table 2). The gene discussed is CASK; the disease is neoplasm.